You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 9, 2025

Drug Price Trends for NDC 00409-3977


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00409-3977

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Bacteriostatic Water for Injection (NDC: 00409-3977)

Introduction

Bacteriostatic water for injection, identified by the NDC code 00409-3977, is a critical component in the healthcare sector, particularly for diluting and dissolving medications before administration. This article delves into the market analysis, current challenges, and price projections for this essential medical product.

Market Size and Growth

The bacteriostatic water for injection market is anticipated to experience significant growth. According to market research, the global market size for bacteriostatic water for injection is projected to reach USD 2.00 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.80%[4].

Applications and End Users

Bacteriostatic water is primarily used for medication dilution, clinical pharmacology, and anti-bacterial applications. The key end users include hospitals, clinics, and other healthcare facilities. The demand is driven by the increasing need for medications that require dilution before administration, particularly in the context of growing medical advancements and a rising population[4].

Distribution Channels

The product is distributed through various channels, including hospital pharmacies, online pharmacies, and other retail outlets. Hospital pharmacies remain a dominant distribution channel due to the high volume of medical procedures requiring bacteriostatic water[4].

Current Challenges: Shortage and Supply Chain Issues

As of recent reports, bacteriostatic water for injection is facing a significant shortage. This shortage is attributed to several factors, including increased demand, manufacturing challenges, and supply chain disruptions. The complex production process and stringent quality control measures add to the manufacturing bottlenecks. Additionally, regulatory compliance issues and global supply chain disruptions exacerbate the shortage[2].

Impact on Patient Care and Medical Procedures

The shortage of bacteriostatic water has far-reaching consequences for patient care. Healthcare providers face difficulties in preparing and administering medications, leading to treatment delays and potential safety risks. This situation also strains healthcare budgets, as more time and resources are needed to manage the shortage[2].

Strategies to Address the Shortage

To mitigate the shortage, healthcare authorities and organizations are working to develop guidelines for the allocation and distribution of available supplies. This includes prioritizing critical patient care and exploring alternative solutions such as new formulations or different packaging options. Streamlining production and supply chain processes is also crucial to optimize efficiency and reduce bottlenecks[2].

Price Projections

The overall pharmaceutical market is expected to see a price increase, with Vizient Inc. projecting a 3.8% drug price inflation, driven in part by specialty pharmaceuticals. While this projection is more general, the specific price trend for bacteriostatic water for injection can be inferred from the broader market dynamics and the current shortage.

Given the shortage and increased demand, it is likely that the prices for bacteriostatic water for injection will rise in the short term. However, long-term price stability may be achieved through efforts to streamline production and improve supply chain efficiency.

Regulatory Factors

Stringent regulations imposed by health authorities to ensure safety and quality can pose challenges for manufacturers. Compliance with these regulations is crucial but can sometimes delay production and distribution, affecting the availability and pricing of bacteriostatic water for injection[2].

Market Outlook

The market outlook for bacteriostatic water for injection is complex, influenced by both demand and supply factors. As the healthcare sector continues to grow, the demand for bacteriostatic water is expected to increase. However, addressing the current shortage and improving manufacturing and supply chain efficiency will be critical to meeting this demand without significant price volatility.

Key Takeaways

  • Market Growth: The global market for bacteriostatic water for injection is projected to reach USD 2.00 billion by 2032, growing at a CAGR of 7.80%.
  • Current Shortage: The product is currently in shortage due to increased demand, manufacturing challenges, and supply chain issues.
  • Impact on Patient Care: The shortage affects patient care by delaying treatments and straining healthcare budgets.
  • Price Projections: Short-term price increases are likely due to the shortage, but long-term stability may be achieved through improved production and supply chain efficiency.
  • Regulatory Factors: Stringent regulations impact production and distribution, affecting availability and pricing.

FAQs

Q: What is the primary use of bacteriostatic water for injection? A: Bacteriostatic water for injection is primarily used as a diluent or solvent for medications that require dilution or dissolution before administration.

Q: Why is there a shortage of bacteriostatic water for injection? A: The shortage is due to increased demand, manufacturing challenges, and supply chain disruptions, including raw material shortages and transportation delays.

Q: How does the shortage affect patient care? A: The shortage can delay treatments, pose safety risks due to inaccuracies in medication administration, and strain healthcare budgets.

Q: What strategies are being implemented to address the shortage? A: Strategies include prioritizing allocation and distribution, exploring alternative solutions, and streamlining production and supply chain processes.

Q: What is the projected market size for bacteriostatic water for injection by 2032? A: The global market size is projected to reach USD 2.00 billion by 2032, growing at a CAGR of 7.80%[4].

Sources

  1. DailyMed: BACTERIOSTATIC WATER injection, solution - DailyMed.
  2. Pipeline Medical: Shortage Of Bacteriostatic Water For Injection? - Pipeline Medical.
  3. Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  4. Market Research Future: Bacteriostatic Water for Injection Market Size, Report 2032.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.